These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 16506783)
21. A triad of residues is functionally transferrable between 5-HT Mosesso R; Dougherty DA J Biol Chem; 2018 Feb; 293(8):2903-2914. PubMed ID: 29298898 [TBL] [Abstract][Full Text] [Related]
22. Soluble, oligomeric, and ligand-binding extracellular domain of the human alpha7 acetylcholine receptor expressed in yeast: replacement of the hydrophobic cysteine loop by the hydrophilic loop of the ACh-binding protein enhances protein solubility. Avramopoulou V; Mamalaki A; Tzartos SJ J Biol Chem; 2004 Sep; 279(37):38287-93. PubMed ID: 15226316 [TBL] [Abstract][Full Text] [Related]
23. Structural characterization of binding mode of smoking cessation drugs to nicotinic acetylcholine receptors through study of ligand complexes with acetylcholine-binding protein. Rucktooa P; Haseler CA; van Elk R; Smit AB; Gallagher T; Sixma TK J Biol Chem; 2012 Jul; 287(28):23283-93. PubMed ID: 22553201 [TBL] [Abstract][Full Text] [Related]
24. The nicotinic receptor ligand binding domain. Sine SM J Neurobiol; 2002 Dec; 53(4):431-46. PubMed ID: 12436411 [TBL] [Abstract][Full Text] [Related]
25. Cysteine accessibility analysis of the human alpha7 nicotinic acetylcholine receptor ligand-binding domain identifies L119 as a gatekeeper. Papke RL; Stokes C; Williams DK; Wang J; Horenstein NA Neuropharmacology; 2011 Jan; 60(1):159-71. PubMed ID: 20650284 [TBL] [Abstract][Full Text] [Related]
26. Identification of novel α7 nicotinic receptor ligands by in silico screening against the crystal structure of a chimeric α7 receptor ligand binding domain. Akdemir A; Edink E; Thompson AJ; Lummis SC; Kooistra AJ; de Graaf C; de Esch IJ Bioorg Med Chem; 2012 Oct; 20(19):5992-6002. PubMed ID: 22959526 [TBL] [Abstract][Full Text] [Related]
27. A role for Leu118 of loop E in agonist binding to the alpha 7 nicotinic acetylcholine receptor. Amiri S; Shimomura M; Vijayan R; Nishiwaki H; Akamatsu M; Matsuda K; Jones AK; Sansom MS; Biggin PC; Sattelle DB Mol Pharmacol; 2008 Jun; 73(6):1659-67. PubMed ID: 18339894 [TBL] [Abstract][Full Text] [Related]
28. Critical elements determining diversity in agonist binding and desensitization of neuronal nicotinic acetylcholine receptors. Corringer PJ; Bertrand S; Bohler S; Edelstein SJ; Changeux JP; Bertrand D J Neurosci; 1998 Jan; 18(2):648-57. PubMed ID: 9425007 [TBL] [Abstract][Full Text] [Related]
29. Design and expression of human alpha7 nicotinic acetylcholine receptor extracellular domain mutants with enhanced solubility and ligand-binding properties. Zouridakis M; Zisimopoulou P; Eliopoulos E; Poulas K; Tzartos SJ Biochim Biophys Acta; 2009 Feb; 1794(2):355-66. PubMed ID: 19059502 [TBL] [Abstract][Full Text] [Related]
30. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study. Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414 [TBL] [Abstract][Full Text] [Related]
31. Structural and functional studies of the nicotinic acetylcholine receptor by solid-state NMR. Williamson PT; Meier BH; Watts A Eur Biophys J; 2004 May; 33(3):247-54. PubMed ID: 14740198 [TBL] [Abstract][Full Text] [Related]
32. A human-specific, truncated α7 nicotinic receptor subunit assembles with full-length α7 and forms functional receptors with different stoichiometries. Lasala M; Corradi J; Bruzzone A; Esandi MDC; Bouzat C J Biol Chem; 2018 Jul; 293(27):10707-10717. PubMed ID: 29784875 [TBL] [Abstract][Full Text] [Related]
33. Thermodynamics and Kinetics of Ion Permeation in Wild-Type and Mutated Open Active Conformation of the Human α7 Nicotinic Receptor. Cottone G; Chiodo L; Maragliano L J Chem Inf Model; 2020 Oct; 60(10):5045-5056. PubMed ID: 32803965 [TBL] [Abstract][Full Text] [Related]
34. Energetics of gating at the apo-acetylcholine receptor transmitter binding site. Purohit P; Auerbach A J Gen Physiol; 2010 Apr; 135(4):321-31. PubMed ID: 20351060 [TBL] [Abstract][Full Text] [Related]
35. Alpha-conotoxin OmIA is a potent ligand for the acetylcholine-binding protein as well as alpha3beta2 and alpha7 nicotinic acetylcholine receptors. Talley TT; Olivera BM; Han KH; Christensen SB; Dowell C; Tsigelny I; Ho KY; Taylor P; McIntosh JM J Biol Chem; 2006 Aug; 281(34):24678-86. PubMed ID: 16803900 [TBL] [Abstract][Full Text] [Related]
36. NMR structural analysis of alpha-bungarotoxin and its complex with the principal alpha-neurotoxin-binding sequence on the alpha 7 subunit of a neuronal nicotinic acetylcholine receptor. Moise L; Piserchio A; Basus VJ; Hawrot E J Biol Chem; 2002 Apr; 277(14):12406-17. PubMed ID: 11790782 [TBL] [Abstract][Full Text] [Related]
37. Investigation of α-conotoxin unbinding using umbrella sampling. Yu R; Tabassum N; Jiang T Bioorg Med Chem Lett; 2016 Feb; 26(4):1296-300. PubMed ID: 26796065 [TBL] [Abstract][Full Text] [Related]
38. The 2.7 A structure of AChBP, homologue of the ligand-binding domain of the nicotinic acetylcholine receptor. Brejc K; van Dijk WJ; Smit AB; Sixma TK Novartis Found Symp; 2002; 245():22-9; discussion 29-32, 165-8. PubMed ID: 12027010 [TBL] [Abstract][Full Text] [Related]
39. Localization by site-directed mutagenesis of a galantamine binding site on α7 nicotinic acetylcholine receptor extracellular domain. Ludwig J; Höffle-Maas A; Samochocki M; Luttmann E; Albuquerque EX; Fels G; Maelicke A J Recept Signal Transduct Res; 2010 Dec; 30(6):469-83. PubMed ID: 21062106 [TBL] [Abstract][Full Text] [Related]
40. Structure, Dynamics, and Ligand Recognition of Human-Specific CHRFAM7A (Dupα7) Nicotinic Receptor Linked to Neuropsychiatric Disorders. Liu D; de Souza JV; Ahmad A; Bronowska AK Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34067314 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]